Literature DB >> 12869705

Stereospecificity of short Rev-derived peptide interactions with RRE IIB RNA.

Alexander Litovchick1, Robert R Rando.   

Abstract

The essential HIV-1 regulatory protein Rev binds to the Rev responsive element (RRE) of the HIV-1 mRNA. A short alpha-helical peptide derived from Rev (Rev 34-50) and a truncated form of the RRE sequence (RRE IIB) provide a useful in vitro system to study the interactions between Rev and RRE. The current studies focus on evaluating the specificity of the binding interactions between Rev 34-50 and RRE IIB. The binding of L- and D-Rev peptides to natural and enantiomeric RRE IIB RNA was studied by fluorescence spectroscopy. D-Rev and L-Rev peptides bind to RRE IIB with similar affinities. CD measurements are consistent with a nonhelical, probably beta-hairpin, conformation for D-Rev in the complex. The binding affinities of D/L Rev peptides to L-RRE IIB RNA are also similar to those with natural D-RRE IIB. Furthermore, the conformations of L- and D-peptides when bound to L-RRE are reciprocal to the conformations of these peptides in complex with D-RRE. RNA footprinting studies show that L- and D-Rev peptides bind to the same site on RRE IIB. Our results demonstrate lack of stereospecificity in RRE RNA-Rev peptide interactions. However, it is quite possible that the interactions between full-length Rev protein and RRE are highly specific.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12869705      PMCID: PMC1370460          DOI: 10.1261/rna.2172103

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  23 in total

Review 1.  Control of human immunodeficiency virus replication by the tat, rev, nef and protease genes.

Authors:  J Karn
Journal:  Curr Opin Immunol       Date:  1991-08       Impact factor: 7.486

2.  HIV-1 Rev regulation involves recognition of non-Watson-Crick base pairs in viral RNA.

Authors:  D P Bartel; M L Zapp; M R Green; J W Szostak
Journal:  Cell       Date:  1991-11-01       Impact factor: 41.582

3.  Specific regulation of mRNA splicing in vitro by a peptide from HIV-1 Rev.

Authors:  J Kjems; A D Frankel; P A Sharp
Journal:  Cell       Date:  1991-10-04       Impact factor: 41.582

4.  Coaxial stacking of helixes enhances binding of oligoribonucleotides and improves predictions of RNA folding.

Authors:  A E Walter; D H Turner; J Kim; M H Lyttle; P Müller; D H Mathews; M Zuker
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

5.  RNA recognition by an isolated alpha helix.

Authors:  R Tan; L Chen; J A Buettner; D Hudson; A D Frankel
Journal:  Cell       Date:  1993-06-04       Impact factor: 41.582

6.  Structure and energetics of ligand binding to proteins: Escherichia coli dihydrofolate reductase-trimethoprim, a drug-receptor system.

Authors:  P Dauber-Osguthorpe; V A Roberts; D J Osguthorpe; J Wolff; M Genest; A T Hagler
Journal:  Proteins       Date:  1988

7.  Mechanism of neomycin and Rev peptide binding to the Rev responsive element of HIV-1 as determined by fluorescence and NMR spectroscopy.

Authors:  K A Lacourciere; J T Stivers; J P Marino
Journal:  Biochemistry       Date:  2000-05-16       Impact factor: 3.162

8.  Real-time kinetics of HIV-1 Rev-Rev response element interactions. Definition of minimal binding sites on RNA and protein and stoichiometric analysis.

Authors:  D I Van Ryk; S Venkatesan
Journal:  J Biol Chem       Date:  1999-06-18       Impact factor: 5.157

9.  Costabilization of peptide and RNA structure in an HIV Rev peptide-RRE complex.

Authors:  R Tan; A D Frankel
Journal:  Biochemistry       Date:  1994-12-06       Impact factor: 3.162

10.  Specific binding of a basic peptide from HIV-1 Rev.

Authors:  J Kjems; B J Calnan; A D Frankel; P A Sharp
Journal:  EMBO J       Date:  1992-03       Impact factor: 11.598

View more
  4 in total

1.  Synthesis and stereospecificity of 4,5-disubstituted oxazolidinone ligands binding to T-box riboswitch RNA.

Authors:  Crina M Orac; Shu Zhou; John A Means; David Boehm; Stephen C Bergmeier; Jennifer V Hines
Journal:  J Med Chem       Date:  2011-08-31       Impact factor: 7.446

2.  Insight into the recognition, binding, and reactivity of catalytic metallodrugs targeting stem loop IIb of hepatitis C IRES RNA.

Authors:  Seth S Bradford; Martin James Ross; Insiya Fidai; James A Cowan
Journal:  ChemMedChem       Date:  2014-04-22       Impact factor: 3.466

3.  RNA drug discovery: Conformational restriction enhances specific modulation of the T-box riboswitch function.

Authors:  Ian Armstrong; Ali H Aldhumani; Jia L Schopis; Fang Fang; Eric Parsons; Chunxi Zeng; Md Ismail Hossain; Stephen C Bergmeier; Jennifer V Hines
Journal:  Bioorg Med Chem       Date:  2020-08-06       Impact factor: 3.641

4.  Selection of cyclic peptide aptamers to HCV IRES RNA using mRNA display.

Authors:  Alexander Litovchick; Jack W Szostak
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-29       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.